Atlas Liquid (ITPP + Cardarine + SR-9009) – Product Information
ITPP is a compound that has been investigated for its potential effects on enhancing oxygen utilization and improving endurance. It is believed to work by increasing the release of oxygen from red blood cells to tissues, potentially leading to improved physical performance. ITPP has shown promise in animal studies, but its effects and safety in humans are not well-established.
Cardarine, also known as GW-501516, is a compound that has been researched for its potential benefits on endurance and fat burning. It has been shown to activate a protein called PPAR-delta, which can influence various metabolic pathways, including those involved in energy expenditure and lipid metabolism.
SR-9009 is classified as a Rev-ErbA agonist. It has been shown to activate a protein called Rev-ErbAÎ±, which plays a role in regulating various metabolic processes in the body. By activating Rev-ErbAÎ±, SR-9009 may have the potential to influence the body’s metabolism, energy expenditure, and endurance capacity.
Given that ITPP, Cardarine, and SR-9009 have different mechanisms of action, the idea behind combining them could be to potentially enhance endurance and aerobic capacity further in a research setting.
- Atlas liquid consists of ITTP, Cardarine, and SR-9009.
- Atlas liquid is offered in 100mg per ml for 30ml, totaling 3000mg.
ITTP or Myo-inositol trispyrophospate is a research compound currently being investigated in hopes of aiding patients weakened by myocardial infarctions due to its ability to increase oxygen supply to damaged cardiac muscle. Designed to make haemoglobin release more oxygen than normal, ITPP boosted exercise levels in the ailing mice by 35% when given dissolved in water. When given by injection into the abdomen, exercise levels rose a massive 60%. Further research is warranted to investigate the potential of ITPP in oxygen transport and endurance training.
GW-501516, also known as Cardarine, is a PPAR agonist. Cardarine is used in research for its potential to facilitate fat-burning by increasing endurance and stamina. A study done on the effects of GW-501516 for enhancing running endurance in Kunming mice demonstrated that a 3-week dosing protocol with GW501516 was able to increase performance related to running of both trained and untrained mice. Similar to training, GW501516 showed an increase in mitochondrial fatty acid oxidation and enhanced fat metabolism in muscle tissue. This could potentially lead to less demanding cardiovascular work, increasing weekly deficits, and resulting in increased fat loss.
A recent study on diet-induced obese mice treated with SR9009 and SR9011 (i.e., two times a day for 30 days) has been reported to display decreased fat mass and markedly improved dyslipidemia and hyperglycemia. The activation of REV-ERB leads to the enhancement of circadian rhythm observed in mice. This affects behavior, sleep cycle, and some functions related to an increment in energy production.
Our content is intended to be used and must be used for informational purposes only. It is very important to do your own analysis and research from Trusted Sources before making any purchase, based on your personal circumstances. You should independently research and verify any information that you find on our Website and wish to rely upon.